van Griensven J, De Weiggheleire A, Delamou A, Smith PJ, Edwards T, et al.
2015-08-10 • Clinical Infectious Diseases
2015-08-10 • Clinical Infectious Diseases
The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola Virus Disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone and Liberia, was ...
van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, et al.
2016-01-07 • New England Journal of Medicine
2016-01-07 • New England Journal of Medicine
BACKGROUND In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with co...
Cohen K, van Cutsem G, Boulle AM, McIlleron HM, Goemaere E, et al.
2008-02-01 • Journal of Antimicrobial Chemotherapy
2008-02-01 • Journal of Antimicrobial Chemotherapy
BACKGROUND AND OBJECTIVES: Nevirapine-containing antiretroviral therapy (ART) and rifampicin-based antitubercular therapy are commonly co-administered in Africa, where nevirapine is ofte...
Hailu ADE, Musa AM, Wasunna M, Balasegaram M, Yifru S, et al.
2010-10-26 • PLOS Neglected Tropical Diseases
2010-10-26 • PLOS Neglected Tropical Diseases
Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is in...